These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38828373)

  • 41. Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia.
    Borer A; Saidel-Odes L; Riesenberg K; Eskira S; Peled N; Nativ R; Schlaeffer F; Sherf M
    Infect Control Hosp Epidemiol; 2009 Oct; 30(10):972-6. PubMed ID: 19712030
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
    Antimicrob Agents Chemother; 2005 Feb; 49(2):760-6. PubMed ID: 15673761
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microbiological and Clinical Characteristics of Bloodstream Infections in General Intensive Care Unit: A Retrospective Study.
    Wu HN; Yuan EY; Li WB; Peng M; Zhang QY; Xie KL
    Front Med (Lausanne); 2022; 9():876207. PubMed ID: 35573022
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Within-Host Genotypic and Phenotypic Diversity of Contemporaneous Carbapenem-Resistant Klebsiella pneumoniae from Blood Cultures of Patients with Bacteremia.
    Cheng S; Fleres G; Chen L; Liu G; Hao B; Newbrough A; Driscoll E; Shields RK; Squires KM; Chu TY; Kreiswirth BN; Nguyen MH; Clancy CJ
    mBio; 2022 Dec; 13(6):e0290622. PubMed ID: 36445082
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment options and clinical outcomes for carbapenem-resistant Enterobacteriaceae bloodstream infection in a Chinese university hospital.
    Li C; Li Y; Zhao Z; Liu Q; Li B
    J Infect Public Health; 2019; 12(1):26-31. PubMed ID: 30145151
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk factors and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary-care hospital in China: an eight-year retrospective study.
    Chen J; Ma H; Huang X; Cui Y; Peng W; Zhu F; Ma S; Rao M; Zhang P; Yang H; Su L; Niu R; Pan P
    Antimicrob Resist Infect Control; 2022 Dec; 11(1):161. PubMed ID: 36536423
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network.
    Zhang Y; Wang Q; Yin Y; Chen H; Jin L; Gu B; Xie L; Yang C; Ma X; Li H; Li W; Zhang X; Liao K; Man S; Wang S; Wen H; Li B; Guo Z; Tian J; Pei F; Liu L; Zhang L; Zou C; Hu T; Cai J; Yang H; Huang J; Jia X; Huang W; Cao B; Wang H
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203488
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk factors for carbapenem-resistant K. pneumoniae bloodstream infection and predictors of mortality in Chinese paediatric patients.
    Zhang Y; Guo LY; Song WQ; Wang Y; Dong F; Liu G
    BMC Infect Dis; 2018 May; 18(1):248. PubMed ID: 29855274
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dissecting bloodstream infections in febrile neutropenic patients with hematological malignancies, a decade-long single center retrospective observational study (2009-2019).
    El Omri H; Padmanabhan R; Taha RY; Kassem N; Elsabah H; Ellahie AY; Santimano AJJ; Al-Maslamani MA; Omrani AS; Elomri A; El Omri A
    J Infect Public Health; 2024 Jan; 17(1):152-162. PubMed ID: 38029491
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of bacteremic pneumonia caused by
    Li F; Zhu J; Zheng Y; Fang Y; Hu L; Xiong J
    Saudi Med J; 2024 Mar; 45(3):241-251. PubMed ID: 38438206
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does Quick Sepsis-Related Organ Failure Assessment Suggest the Use of Initial Empirical Carbapenem Therapy in Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Bacteria? :A Multicenter Case-Control Study.
    Mitsuboshi S; Tsuruma N; Watanabe K; Takahashi S; Nakashita M; Ito A; Kobayashi K; Tsugita M
    Jpn J Infect Dis; 2019 Mar; 72(2):124-126. PubMed ID: 30381688
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias.
    Micozzi A; Gentile G; Minotti C; Cartoni C; Capria S; Ballarò D; Santilli S; Pacetti E; Grammatico S; Bucaneve G; Foà R
    BMC Infect Dis; 2017 Mar; 17(1):203. PubMed ID: 28283020
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Associated factors and clinical outcomes of bloodstream infection due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae during febrile neutropenia.
    Ben-Chetrit E; Eldaim MA; Bar-Meir M; Dodin M; Katz DE
    Int J Antimicrob Agents; 2019 Apr; 53(4):423-428. PubMed ID: 30572008
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk factors for mortality of patients with ceftriaxone resistant E. coli bacteremia receiving carbapenem versus beta lactam/beta lactamase inhibitor therapy.
    Nasir N; Ahmed S; Razi S; Awan S; Mahmood SF
    BMC Res Notes; 2019 Sep; 12(1):611. PubMed ID: 31547853
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antimicrobial treatment of monomicrobial phenotypic carbapenem-resistant Klebsiella pneumoniae bacteremia: Two are better than one.
    Tsai WC; Syue LS; Ko WC; Lo CL; Lee NY
    J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 2):1219-1228. PubMed ID: 34635426
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Third-generation cephalosporin resistance of community-onset Escherichia coli and Klebsiella pneumoniae bacteremia in a secondary hospital.
    Lee S; Han SW; Kim KW; Song DY; Kwon KT
    Korean J Intern Med; 2014 Jan; 29(1):49-56. PubMed ID: 24574833
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of empiric antimicrobial therapy on outcomes in patients with Escherichia coli and Klebsiella pneumoniae bacteremia: a cohort study.
    Thom KA; Schweizer ML; Osih RB; McGregor JC; Furuno JP; Perencevich EN; Harris AD
    BMC Infect Dis; 2008 Sep; 8():116. PubMed ID: 18793400
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Trends in antimicrobial resistance in bloodstream infections at a large tertiary-care hospital in China: a 10-year retrospective study (2010-2019).
    Liu C; Xu M; Li X; Dong H; Ming L
    J Glob Antimicrob Resist; 2022 Jun; 29():413-419. PubMed ID: 34800707
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Carbapenem-resistant Klebsiella pneumoniae bloodstream infections in haematological malignances and hematopoietic stem cell transplantation: Clinical impact of combination therapy in a 10-year Brazilian cohort.
    de Souza ILA; Cappellano P; Ferreira DB; Bergamasco MD; das Chagas Neto TC; Kerbauy FR; Baiocchi OCG; Pignatari ACC
    PLoS One; 2024; 19(1):e0297161. PubMed ID: 38277372
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk factors for 28-day mortality in elderly patients with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae bacteremia.
    Ku NS; Kim YC; Kim MH; Song JE; Oh DH; Ahn JY; Kim SB; Kim HW; Jeong SJ; Han SH; Kim CO; Song YG; Kim JM; Choi JY
    Arch Gerontol Geriatr; 2014; 58(1):105-9. PubMed ID: 23988261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.